These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38656186)
21. Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy. Bue M; Sou T; Okkels ASL; Hanberg P; Thorsted A; Friberg LE; Andersson TL; Öbrink-Hansen K; Christensen S Int J Infect Dis; 2020 Mar; 92():133-140. PubMed ID: 31978581 [TBL] [Abstract][Full Text] [Related]
22. Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI. Chihara S; Ishigo T; Kazuma S; Matsumoto K; Morita K; Masuda Y Antibiotics (Basel); 2024 Aug; 13(8):. PubMed ID: 39200055 [TBL] [Abstract][Full Text] [Related]
27. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy. Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study. Maimongkol P; Yonwises W; Anugulruengkitt S; Sophonphan J; Treyaprasert W; Wacharachaisurapol N Int J Infect Dis; 2022 Jul; 120():96-102. PubMed ID: 35489632 [TBL] [Abstract][Full Text] [Related]
29. Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy. Hambrick HR; Cervantes F; Dong M; Tang P; Arbough T; Vinks AA; Mizuno T; Goldstein SL; Kaplan J; Girdwood ST J Pediatr Pharmacol Ther; 2024 Apr; 29(2):180-187. PubMed ID: 38596427 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy. Awissi DK; Beauchamp A; Hébert E; Lavigne V; Munoz DL; Lebrun G; Savoie M; Fagnan M; Amyot J; Tétreault N; Robitaille R; Varin F; Lavallée C; Pichette V; Leblanc M Pharmacotherapy; 2015 Jun; 35(6):600-7. PubMed ID: 26095008 [TBL] [Abstract][Full Text] [Related]
31. Reappraisal of the Optimal Dose of Meropenem in Critically Ill Infants and Children: a Developmental Pharmacokinetic-Pharmacodynamic Analysis. Wang ZM; Chen XY; Bi J; Wang MY; Xu BP; Tang BH; Li C; Zhao W; Shen AD Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513801 [TBL] [Abstract][Full Text] [Related]
32. Optimization of meropenem dosage in the critically ill population based on renal function. Crandon JL; Ariano RE; Zelenitsky SA; Nicasio AM; Kuti JL; Nicolau DP Intensive Care Med; 2011 Apr; 37(4):632-8. PubMed ID: 21136037 [TBL] [Abstract][Full Text] [Related]
33. Meropenem for the Pharmacological Treatment of Severe Infections in Critically Ill Pediatric Patients: Breakthrough Standard Treatment Strategies Based on PK/PD. He X; Liu X; Gong X; Wang L; Chen F Curr Drug Metab; 2023; 24(1):5-15. PubMed ID: 36974414 [TBL] [Abstract][Full Text] [Related]
34. Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization. Cojutti PG; Gatti M; Rinaldi M; Tonetti T; Laici C; Mega C; Siniscalchi A; Giannella M; Viale P; Pea F Front Pharmacol; 2021; 12():781892. PubMed ID: 34955851 [No Abstract] [Full Text] [Related]
35. Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Meropenem in Critically Ill Patients. Boonpeng A; Jaruratanasirikul S; Jullangkoon M; Samaeng M; Wattanavijitkul T; Bhurayanontachai R; Pattharachayakul S Antimicrob Agents Chemother; 2022 Nov; 66(11):e0084522. PubMed ID: 36226944 [TBL] [Abstract][Full Text] [Related]